Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir.
about
Enhancement of scleral macromolecular permeability with prostaglandinsThe role of ganciclovir for the management of cytomegalovirus retinitis in HIV patients: Pharmacological review and update on new developments.An algorithmic approach to treatment of cytomegalovirus retinitis.Local treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.Diagnosis and management of viral retinitis in the acute retinal necrosis syndrome.Virus infections of the eye.New developments in sustained release drug delivery for the treatment of intraocular diseaseCytomegalovirus retinitis in patients with acquired immune deficiency syndrome.Developments in the treatment of uveitis.Evaluation of retinal toxicity and efficacy of the anticytomegalovirus compound 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine.Treatment outcomes of reduced-dose intravitreal ganciclovir for cytomegalovirus retinitis.New therapeutic options in uveitis.A review of antiviral drugs and other compounds with activity against feline herpesvirus type 1An intravaginal ring for the simultaneous delivery of multiple drugs.Local therapy for cytomegalovirus retinitis.Biodegradable polymeric device for sustained intravitreal release of ganciclovir in rabbits.Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity.Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment.Cytomegalovirus retinitis: are intraocular devices the answer?Treatment of cytomegalovirus retinitis with intraocular implants.Intravitreal sustained-release ganciclovir implants for severe bilateral cytomegalovirus retinitis after stem cell transplantation.New biodegradable networks of poly(N-vinylpyrrolidinone) designed for controlled nonburst degradation in the vitreous body.Retinal detachment in cytomegalovirus retinitis: intravenous versus intravitreal therapy.Evolution of Intravitreal Therapy for Retinal Diseases - From CMV to CNV: The LXXIV Edward Jackson Memorial Lecture.Cytomegalovirus retinitis in persons with AIDS.Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant.The spectrum of eye disease in children with AIDS due to vertically transmitted HIV disease: clinical findings, virology and recommendations for surveillance.
P2860
Q28345276-452A6CC1-4670-4524-9626-599515F0E2BEQ33400808-F0263B02-B805-44EF-AB3D-72139B123C0EQ33569542-675E35D7-0EC6-4848-87E4-593F71E43F9BQ33569565-27CC4433-6C48-4718-B863-94FFD4009E2FQ33569740-EBD80794-3E3B-4D39-A18C-E3C22A9BE1F1Q33682990-513294CE-7AFC-47D2-93D3-52167E236F2DQ33760311-DC9F07AB-32C2-4862-B06A-F01BBA8C4ACDQ33809056-47A5460D-7032-4123-966B-5CB199B4B052Q34481964-257FF219-4CAC-4282-8459-FD79DC1D681EQ35116034-08D3A766-8F96-4147-96C2-877CF13C033BQ36811157-CC4523FD-BF51-497E-8675-3408707DC358Q36888392-41C6E7D9-4127-491F-BFB2-FBBF0C1E0B63Q37059841-047F3102-F072-44FC-BFEE-7C55E4C74D33Q37379716-EB025E42-000E-46ED-A52C-CA5FD0C6778BQ38553191-033C6C44-A868-4D91-938D-A5E3B100DBF7Q38557085-1E1C1F30-A374-4E55-8D06-53E3B0AAB2F5Q38648168-971CB219-3C51-4E65-BCC1-7C8453DAE9B4Q39713018-03758BED-D6F9-416A-8AB8-161E365B8E3CQ39714123-28DF1528-A6ED-499F-A413-51EB946E0FB9Q41722152-93CB7E71-3A6F-4998-A9CF-FFE2236AFB52Q43925066-57152D4E-7BD5-46D6-92DE-0E783B0CD6D6Q44321555-714BF8B6-1921-4D68-8090-9809FA1C00FBQ44369375-EF40CDBF-D061-4AAB-A784-8A7C90192F68Q47729194-DDE035D2-E383-427F-A0A3-B4BABEB226F1Q50008558-CE04CFDE-C1FA-43D0-BAFE-9CB36B311AD2Q51393030-722ED448-F34E-4B67-8C03-F0264F410576Q51547365-BBB582C7-4FDD-4713-A5CD-1BA1A32FA01A
P2860
Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir.
@en
Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir.
@nl
type
label
Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir.
@en
Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir.
@nl
prefLabel
Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir.
@en
Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir.
@nl
P2093
P1433
P1476
Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir.
@en
P2093
P304
P356
10.1001/ARCHOPHT.1993.01090020077027
P407
P577
1993-02-01T00:00:00Z